share_log

Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $273

Benzinga ·  Jul 25, 2023 08:45

Guggenheim analyst Sandy Draper maintains Medpace Hldgs (NASDAQ:MEDP) with a Buy and raises the price target from $252 to $273.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment